Back to Screener

Concord Medical Services Holding Limited (CCM)

Price$5.00
Value ScoreB
Growth ScoreB
Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)14.15%
Price vs S&P 500 (4W)19.84%
VGM Score66.82
Market Capitalization$3.16M

All Metrics

Book Value / Share (Quarterly)$-0.89
P/TBV (Annual)2.11x
Revenue Growth (3Y)33.50%
Price vs S&P 500 (YTD)16.99%
Gross Margin (TTM)-16.51%
Net Profit Margin (TTM)-76.10%
EPS (TTM)$-0.18
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-0.18
Revenue Growth (5Y)7.36%
EPS (Annual)$-0.35
ROI (Annual)-17.08%
Gross Margin (Annual)-32.28%
Net Profit Margin (5Y Avg)-115.28%
Cash / Share (Quarterly)$0.20
Revenue Growth QoQ (YoY)97.22%
ROA (Last FY)-4.58%
Revenue Growth TTM (YoY)40.12%
EBITD / Share (TTM)$-0.21
ROE (5Y Avg)-21.09%
Operating Margin (TTM)-90.64%
Cash Flow / Share (Annual)$-0.63
Net Income / Employee (Annual)$-76,500
EV / Revenue (TTM)6.18x
Net Interest Coverage (TTM)-2.79x
ROA (TTM)-2.42%
EPS Incl Extra (Annual)$-0.35
Current Ratio (Annual)0.46x
Quick Ratio (Quarterly)0.10x
3-Month Avg Trading Volume0.02M
52-Week Price Return-32.47%
Revenue / Employee (TTM)$151,952
Tangible BV / Share (Quarterly)$-1.33
P/S Ratio (Annual)0.31x
Asset Turnover (Annual)0.08x
52-Week High$10.77
Operating Margin (5Y Avg)-148.49%
EPS Excl Extra (Annual)$-0.35
CapEx CAGR (5Y)-7.16%
Tangible BV CAGR (5Y)-23.24%
26-Week Price Return30.08%
Quick Ratio (Annual)0.24x
13-Week Price Return35.81%
Total Debt / Equity (Annual)2.14x
Current Ratio (Quarterly)0.42x
Enterprise Value$559.16M
Revenue / Share Growth (5Y)69.90%
Asset Turnover (TTM)0.10x
Book Value / Share Growth (5Y)-26.58%
Revenue / Employee (Annual)$117,149
Inventory Turnover (Annual)12.55x
Pretax Margin (Annual)-177.91%
Cash / Share (Annual)$0.40
3-Month Return Std Dev73.55%
Gross Margin (5Y Avg)-7.14%
Net Income / Employee (TTM)$-40,487
ROE (Last FY)-53.70%
Net Interest Coverage (Annual)-3.63x
EPS Basic Excl Extra (Annual)$-0.35
P/FCF (TTM)0.27x
Receivables Turnover (TTM)6.53x
EPS Incl Extra (TTM)$-0.18
Receivables Turnover (Annual)3.92x
ROI (TTM)-63.60%
P/S Ratio (TTM)0.24x
Pretax Margin (5Y Avg)-160.01%
Revenue / Share (Annual)$5.32
Tangible BV / Share (Annual)$0.54
Price vs S&P 500 (52W)-60.67%
Year-to-Date Return27.72%
5-Day Price Return0.41%
EPS Normalized (Annual)$-0.35
ROA (5Y Avg)-5.56%
Net Profit Margin (Annual)-103.72%
Month-to-Date Return24.81%
Cash Flow / Share (TTM)$-0.07
EBITD / Share (Annual)$-0.45
Operating Margin (Annual)-124.26%
LT Debt / Equity (Annual)1.14x
ROI (5Y Avg)-7.87%
EPS Basic Excl Extra (TTM)$-0.18
P/B Ratio (Annual)2.52x
Inventory Turnover (TTM)15.23x
Pretax Margin (TTM)-130.97%
Book Value / Share (Annual)$0.50
Price vs S&P 500 (13W)26.07%
Beta-1.03x
P/FCF (Annual)0.33x
Revenue / Share (TTM)$6.95
ROE (TTM)-11.58%
52-Week Low$3.18
vGradeB
gGradeB
mGradeC
vgmGradeB
Show chart for

Analyst Recommendations

Sep 2021
Oct 2021
Nov 2021
Dec 2021
2.13
2.13
2.13
2.13

About

Concord Medical Services Holdings Ltd operates radiotherapy, diagnostic imaging, and cancer treatment centers throughout China. The company provides premium cancer and proton therapy services while also generating revenue through medical equipment leasing and hospital management services.